Christian Schwöppe
0000-0001-9829-2731
1 paper found
Refreshing results…
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
Missing publications? Search for publications with a matching author name.